AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CAMELLIA PLC

Regulatory Filings Nov 11, 2024

7545_rns_2024-11-11_f951b396-932c-4459-8a54-3fdecf2f4565.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6935L

Camellia PLC

11 November 2024

11 November 2024

Camellia Plc

(the "Company")

Sale of Bangladesh associate companies

Further to the announcement made on 31 October 2024, the Company is pleased to confirm that, following receipt of regulatory approvals, its subsidiaries have sold their entire holdings in United Finance Limited (38.4% ownership) and United Insurance Company Limited (37% ownership) by way of block trades on the Dhaka Stock Exchange on 10 and 11 November 2024.  The estimated cash proceeds are expected to total Tk1,220 million (approximately £7.9 million).  Camellia's net assets attributable to these holdings as at 30 June 2024 were £9.5 million. Settlement of the trades is expected to occur this week.

This represents a further step in the simplification and rationalisation of the Company's business.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

Enquiries

Camellia Plc                                                      01622 746655

Byron Coombs, Chief Executive Officer

Oliver Capon, Chief Financial Officer

Panmure Liberum                                        020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

H/Advisors Maitland 

PR

William Clutterbuck                                             07785 292617

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DISBBBPTMTMBMII

Talk to a Data Expert

Have a question? We'll get back to you promptly.